Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1990-06-13
1991-12-10
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514574, 562567, 562584, 426 72, A61K 31205
Patent
active
050718746
ABSTRACT:
L-carnitine magnesium citrate and a process for its production, starting from a magnesium compound, citric acid and L-carnitine, as well as the use of the product as a combination preparation in sports nutrition or as a pharmacological active ingredient.
REFERENCES:
patent: 3810994 (1974-05-01), Wiegand
patent: 4172072 (1979-10-01), Ashmead
patent: 4255449 (1981-03-01), Cavazza
patent: 4371618 (1983-02-01), Cavazza
patent: 4537772 (1985-08-01), Alexander et al.
patent: 4602039 (1986-07-01), Cavazza
patent: 4806282 (1989-02-01), Tinti et al.
patent: 4855289 (1989-08-01), Wester et al.
patent: 4871550 (1989-10-01), Millman
patent: 4883786 (1989-11-01), Puricelli
patent: 4895980 (1990-01-01), Walsdorf et al.
Greff, Chem. Abst; vol. 112, #25391X (19.
Strack et al., Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, vol. 318, (1960), pp. 129-137.
Kohl Willibald F.
Scholl Thomas
Lonza Ltd.
Reamer James H.
LandOfFree
L-carnitine magnesium citrate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with L-carnitine magnesium citrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-carnitine magnesium citrate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040968